8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Mitral Regurgitation After Percutaneous Mitral Valvuloplasty : Insights Into Mechanisms and Impact on Clinical Outcomes

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          OBJECTIVES

          The aim of this study was to assess the incidence, mechanisms, and outcomes of mitral regurgitation (MR) after percutaneous mitral valvuloplasty (PMV).

          BACKGROUND

          Significant MR continues to be a major complication of PMV, with a wide range in clinical presentation and prognosis.

          METHODS

          Consecutive patients with mitral stenosis undergoing PMV were prospectively enrolled. MR severity was evaluated by using quantitative echocardiographic criteria, and its mechanism was characterized by 3-dimensional transesophageal echocardiography, divided broadly into 4 categories based on the features contributing to the valve damage. B-type natriuretic peptide levels were obtained before and 24 h after the procedure. Endpoints estimated cardiovascular death or mitral valve (MV) replacement due to predominant MR.

          RESULTS

          A total of 344 patients, ages 45.1 ± 12.1 years, of whom 293 (85%) were women, were enrolled. Significant MR after PMV was found in 64 patients (18.6%). The most frequent mechanism of MR was commissural, which occurred in 22 (34.4%) patients, followed by commissural with posterior leaflet in 16 (25.0%), leaflets at central scallop or subvalvular damage in 15 (23.4%), and central MR in 11 (17.2%). During the mean follow-up period of 3 years (range 1 day to 10.6 years), 60 patients reached the endpoint. The event-free survival rates were similar among patients with mild or commissural MR, whereas patients with damaged central leaflet scallop or subvalvular apparatus had the worst outcome, with an event-free survival rate at 1 year of only 7%. Long-term outcome was predicted by net atrioventricular compliance (C n) at baseline and post-procedural variables, including valve area, mean gradient, and magnitude of decrease in B-type natriuretic peptide levels, adjusted for the mechanism of MR.

          CONCLUSIONS

          Significant MR following PMV is a frequent event, mainly related to commissural splitting, with favorable clinical outcome. Parameters that express the relief of valve obstruction and the mechanism by which MR develops were predictors of long-term outcomes.

          Related collections

          Author and article information

          Journal
          101467978
          35679
          JACC Cardiovasc Imaging
          JACC Cardiovasc Imaging
          JACC. Cardiovascular imaging
          1936-878X
          1876-7591
          19 January 2021
          16 September 2020
          December 2020
          04 February 2021
          : 13
          : 12
          : 2513-2526
          Affiliations
          [a ]Hospital das Clinicas, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil;
          [b ]Cardiac Ultrasound Lab, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA;
          [c ]Laboratory of Molecular Pathology, Department of Pathological Anatomy and Legal Medicine, School of Medicine of the Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil;
          [d ]Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA;
          [e ]Department of Morphology, Institute of Biological Sciences, Federal University of Minas Gerais, and National Institutes for Science and Technology, Belo Horizonte, Minas Gerais, Brazil;
          [f ]The Center for Excellence in Vascular Biology, Cardiovascular Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA;
          [g ]Department of Cardiology, Blacktown Hospital, University of Western Sydney, New South Wales, Australia.
          Author notes
          ADDRESS FOR CORRESPONDENCE: Dr. Maria Carmo P. Nunes, Department of Internal Medicine, School of Medicine of the Federal University of Minas Gerais, Av. Professor Alfredo Balena, 190, Santa Efigênia, 30130 100-Belo Horizonte, MG, Brazil. mcarmo@ 123456waymail.com.br .
          Article
          PMC7861508 PMC7861508 7861508 nihpa1663653
          10.1016/j.jcmg.2020.07.020
          7861508
          32950446
          01930b5e-e06c-422c-9f59-35e525e2828e
          History
          Categories
          Article

          percutaneous mitral valvuloplasty,mitral regurgitation,mitral stenosis,outcomes

          Comments

          Comment on this article